All HIV articles – Page 10
-
Long ReadsGender-specific approaches to HIV prevention: addressing the needs of women and girls
With nearly 25 million deaths and an estimated 33.2 million people (including 15.4 million women) living with the virus globally, HIV/AIDS is on the brink of becoming the most devastating pandemic the world has ever seen.
-
NewsHIV: Thwarting a protein in the hope of a better quality of life
The sustained activation of the body’s immune system for people living with HIV leads to chronic inflammation that can cause associated complications such as cardiovascular diseases, osteoporosis or neurocognitive decline.
-
NewsStudy uncovers mediators of persistent HIV viremia
Researchers examining people with non-suppressible HIV viremia (NSV) despite receiving antiretroviral therapy (ART) have found large reservoirs of proviruses inserted into transcriptionally active regions of immune cell genomes.
-
NewsCOVID-19 compromised U.S. gains in controlling HIV and worsened health disparities
The COVID-19 pandemic slowed previous gains made in controlling HIV blood levels and worsened health disparities, according to researchers leading the largest U.S. evaluation of the impact of the public health crisis on people with HIV.
-
NewsResearchers invent single, rapid test for both HIV and TB
Scientists have developed a new and rapid test that can detect both HIV and tuberculosis at the same time with just a small amount of blood.
-
NewsVaginal film that dissolves in 30 days may offer HIV prevention method for women
A vaginal film designed to slowly dissolve over the course of 30 days is being put to the test for the first time in a study that aims to determine its feasibility and acceptability as a potential HIV prevention method for women.
-
NewsTB vaccine discovery paves path to end no. 1 killer of people living with HIV
Scientists have discovered a tuberculosis (TB) vaccination strategy that could prevent the leading cause of death among people worldwide living with HIV.
-
NewsClinical trial of HIV vaccine begins in United States and South Africa
A trial of a preventive HIV vaccine candidate has begun enrollment in the United States and South Africa. The Phase 1 trial will evaluate a novel vaccine known as VIR-1388 for its safety and ability to induce an HIV-specific immune response in people. Source: NIAID Transmission electron micrograph ...
-
News’Dormant’ HIV produces RNA and proteins during anti-retroviral therapy
Two independent groups of researchers report that a subset of ‘dormant’ HIV-infected cells spontaneously produce HIV RNA and proteins that may impact patients’ HIV-specific immune responses.
-
NewsTwo autopsies reveal secrets of HIV reservoirs
A research team shows for the first time that HIV reservoirs are concentrated in the spleen and lymph nodes, and that they can travel throughout the body.
-
NewsBlood cancer drug shows promise in killing ‘silent’ HIV cells
An existing blood cancer drug has shown promise in killing ‘silent’ HIV cells and delaying reinfections – a significant pre-clinical discovery that could lead to a future cure for the disease.
-
NewsTests of new antifungal therapy for fungal meningitis are successful
Researchers have successfully tested a new oral formulation of the antifungal medication amphotericin among people who had HIV and cryptococcal meningitis - a common fungal infection around the brain.
-
NewsGut microbiome can increase risk and severity of HIV and EBV disease
Researchers have shown that the microbiome has a significant impact on the acquisition of Epstein-Barr virus (EBV) and human immunodeficiency virus-1 (HIV) infection and plays a role in the course of disease.
-
NewsScientists discover broadly neutralizing antibodies that contribute to HIV control
Researchers have investigated and revealed how neutralizing antibodies, including those described as broadly neutralizing, contribute to HIV control.
-
NewsNew HIV drug formulation could improve treatment outcomes for children worldwide
Researchers have confirmed the dosing, safety and effectiveness of a drug formulation designed for treating children with human immunodeficiency virus (HIV).
-
NewsKey gene for resistance to HIV replication found in people of African ancestry
Scientists have identified a novel region in the genome that is only variable in populations of African ancestries and provided evidence that the gene CHD1L acts to limit HIV replication in a subset of white blood cells.
-
NewsResearchers create total synthesis of HIV replication inhibitor
Scientists appear to have discovered a way to produce a true structure of the rare but naturally-occurring anti-HIV compound Lancilactone C from start to finish.
-
NewsJak inhibitors can decay viral reservoir in people with HIV
New research demonstrates the potential of Jak inhibitors, specifically ruxolitinib, to significantly decay the viral reservoir in people with HIV, offering a novel pathway toward long-term remission or a cure.
-
NewsMicrobiologist and virologist creating Global Pandemic Research Alliance
Columbia University virologist Professor David Ho and The University of Hong Kong (HKU) microbiologist Professor Kwok-yung Yuen are teaming up to create a global alliance for conducting research in emerging infectious diseases.
-
NewsDigital test directly measures HIV viral load
Researchers have developed a time and cost-efficient digital assay that can directly measure the presence of HIV in a single drop of blood.